Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$14,590,338
+$2,341,954 QoQ
Shares Held
57,981
+3.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#753
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOSTER & MOTLEY INC holds $58,493,564 across 11 Drug Manufacturers - General names. ABBV ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
57,981 | $14,590,338 | |
| 2 | AMGN |
Amgen Inc
|
32,896 | $11,912,299 | |
| 3 | JNJ |
Johnson & Johnson
|
45,340 | $11,514,999 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,282 | $4,919,237 | |
| 5 | PFE |
Pfizer Inc
|
168,239 | $4,051,195 | |
| 6 | NVS |
Novartis AG
|
21,447 | $3,361,173 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,454 | $3,252,879 | |
| 8 | GSK |
GSK plc
|
42,484 | $2,227,011 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,590,338 | 57,981 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $12,248,384 | 56,317 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $12,792,926 | 55,989 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $13,369,119 | 57,740 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $10,823,687 | 58,311 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $12,087,627 | 57,692 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $10,403,446 | 58,545 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $11,383,734 | 57,645 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $10,429,102 | 60,804 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $10,906,697 | 59,894 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $9,104,332 | 58,749 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $8,598,078 | 57,682 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $7,754,250 | 57,554 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,028,151 | 56,649 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $8,989,879 | 55,627 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,478,181 | 55,720 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $8,404,042 | 54,871 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,670,453 | 53,485 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $7,102,677 | 52,457 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,526,827 | 51,236 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,821,460 | 51,682 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $5,046,947 | 46,636 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $5,058,122 | 47,206 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $4,191,006 | 47,848 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,696,243 | 47,833 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $3,562,796 | 46,762 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||